Office of the Director, National Institutes of Health; Notice of Meeting, 46859-46860 [2021-17895]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 159 / Friday, August 20, 2021 / Notices
License applications submitted in
response to this Notice will be
presumed to contain business
confidential information and any release
of information in these license
applications will be made only as
required and upon a request under the
Freedom of Information Act, 5 U.S.C.
552.
Dated: August 16, 2021.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2021–17849 Filed 8–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council, September 09, 2021, 10:00 a.m.
to September 10, 2021, 12:45 p.m.,
National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD, 20892 which
was published in the Federal Register
on August 09, 2021, FR Doc 2021–
16952, 86 FR 43557.
The meeting notice is amended to
change and adjust the Opening and
Closing times on the Subcommittees
and Executive Sessions. The meeting is
partially Closed to the public.
Dated: August 17, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17876 Filed 8–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
Jkt 253001
Dated: August 17, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
National Institutes of Health
17:27 Aug 19, 2021
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; AMP AIM
Technology and Analytic Cores Review.
Date: September 15, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 814,
Bethesda, MD 20892, 301–451–4838, mak2@
mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; AMP–AIM
Disease Team Review.
Date: September 17, 2021.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yin Liu, Ph.D., MD
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis, and
Musculoskeletal and Skin Diseases, National
Institute of Health, Bethesda, MD 20892,
301–496–0505 liuy@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
[FR Doc. 2021–17873 Filed 8–19–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Council of Councils.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
46859
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The open sessions will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: September 17, 2021.
Time: 10:00 a.m. to 12:10 p.m.
Agenda: Call to Order and Introductions;
Announcements and Updates; NIH Program
Updates; Scientific Talks and Other Business
of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Name of Committee: Council of Councils.
Closed: September 17, 2021.
Time: 12:10 p.m. to 1:10 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Open: September 17, 2021.
Time: 1:30 p.m. to 5:10 p.m.
Agenda: NIH Program Updates; Scientific
Talks and Other Business of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Robert W. Eisinger, Ph.D.,
Executive Secretary, Council of Councils,
Senior Scientific Advisor, Division of
Program Coordination, Planning, and
Strategic Initiatives, Office of the Director,
NIH, Building 1, Room 258, One Center
Drive, Bethesda, MD 20892, robert.eisinger@
nih.gov, 301–451–0455.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
E:\FR\FM\20AUN1.SGM
20AUN1
46860
Federal Register / Vol. 86, No. 159 / Friday, August 20, 2021 / Notices
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institute of General Medical
Sciences; Notice of Closed Meetings
[FR Doc. 2021–17895 Filed 8–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Study Section DDK–
D.
Date: October 19–21, 2021.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: II Democracy Plaza, Democracy 2,
6707 Democracy Blvd., Bethesda, MD 20817
(Video Meeting).
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20817, 301–496–9010,
hoffertj@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 17, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17880 Filed 8–19–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:33 Aug 19, 2021
Jkt 253001
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS National and
Regional Resource (R24) Applications.
Date: October 20, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Ruth Grossman, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, (301) 435–2409 grossmanrs@
mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Review of SuRE Applications.
Date: November 9, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, 301–594–3907, pikebr@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Review of SuRE Applications
Date: November 10, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Ruth Grossman, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Center Drive, Room 3AN18, Bethesda, MD
20892, (301) 435–2409, grossmanrs@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: August 17, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17874 Filed 8–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Collaborative
Innovation Awards Review Meeting.
Date: September 23, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037 Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20817, 301–435–0810,
lourdes.ponce@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B–Cooperative Agreements;
E:\FR\FM\20AUN1.SGM
20AUN1
]]>Agencies
[Federal Register Volume 86, Number 159 (Friday, August 20, 2021)]
[Notices]
[Pages 46859-46860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17895]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Council of
Councils.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The open sessions will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov).
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4), and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such
as patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Council of Councils.
Open: September 17, 2021.
Time: 10:00 a.m. to 12:10 p.m.
Agenda: Call to Order and Introductions; Announcements and
Updates; NIH Program Updates; Scientific Talks and Other Business of
the Committee.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Name of Committee: Council of Councils.
Closed: September 17, 2021.
Time: 12:10 p.m. to 1:10 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Open: September 17, 2021.
Time: 1:30 p.m. to 5:10 p.m.
Agenda: NIH Program Updates; Scientific Talks and Other Business
of the Committee.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert W. Eisinger, Ph.D., Executive Secretary,
Council of Councils, Senior Scientific Advisor, Division of Program
Coordination, Planning, and Strategic Initiatives, Office of the
Director, NIH, Building 1, Room 258, One Center Drive, Bethesda, MD
20892, [email protected], 301-451-0455.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Council of Council's home
page at https://dpcpsi.nih.gov/council/ where an agenda will be
posted before the meeting date.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
[[Page 46860]]
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: August 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-17895 Filed 8-19-21; 8:45 am]
BILLING CODE 4140-01-P
